The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12470
StudyName: Eligibility RE-DEEM Acute Coronary Syndrome NCT00621855
Date of export from the portal: 02.07.2020
Date of Upload / last change: 21.11.2015
License: Creative Commons BY 4.0

----

Description: 
The purpose of this trial is to evaluate the safety and indicators of efficacy of up to 4 doses of orally administered dabigatran etexilate, administered twice daily, compared to placebo when given in addition to dual antiplatelet treatment in patients with an index event (MI) at high risk for new ischaemic cardiovascular events.
https://www.clinicaltrials.gov/ct2/show/NCT00621855
